| MDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21 AE Vilgelm, N Saleh, R Shattuck-Brandt, K Riemenschneider, L Slesur, ... Science Translational Medicine 11 (505), eaav7171, 2019 | 102 | 2019 |
| The lysosomal TRPML1 channel regulates triple negative breast cancer development by promoting mTORC1 and purinergic signaling pathways M Xu, S Almasi, Y Yang, C Yan, AM Sterea, AKR Syeda, B Shen, ... Cell Calcium 79, 80-88 (Co-first author), 2019 | 70 | 2019 |
| Targeted Deletion of CXCR2 in Myeloid Cells Alters the Tumor Immune Environment to Improve Antitumor Immunity J Yang, C Yan, AE Vilgelm, SC Chen, GD Ayers, CA Johnson, ... Cancer Immunology Research 9 (2), 200-213 (Co-first author), 2021 | 57 | 2021 |
| Hiding in the dark: pan-cancer characterization of expression and clinical relevance of CD40 to immune checkpoint blockade therapy C Yan, A Richmond Molecular Cancer 20, 1-5, 2021 | 50 | 2021 |
| Immunomodulatory Properties of PI3K/AKT/mTOR and MAPK/MEK/ERK Inhibition Augment Response to Immune Checkpoint Blockade in Melanoma and Triple-Negative Breast Cancer Z Zhang, A Richmond, C Yan International Journal of Molecular Sciences 23 (13), 7353, 2022 | 47 | 2022 |
| Distinct origin of the Y and St genome in Elymus species: evidence from the analysis of a large sample of St genome species using two nuclear genes C Yan, G Sun, D Sun PLoS One 6 (10), e26853, 2011 | 44 | 2011 |
| Inhibition of the PI3K/mTOR Pathway in Breast Cancer to Enhance Response to Immune Checkpoint Inhibitors in Breast Cancer C Yan, J Yang, N Saleh, SC Chen, GD Ayers, VG Abramson, IA Mayer, ... International Journal of Molecular Sciences 22 (10), 5207, 2021 | 40 | 2021 |
| Multiple origins of allopolyploid wheatgrass Elymus caninus revealed by RPB2, PepC and TrnD/T genes C Yan, G Sun Molecular Phylogenetics and Evolution 64 (3), 441-451, 2012 | 35 | 2012 |
| Myeloid-derived suppressor cell depletion therapy targets IL-17A-expressing mammary carcinomas B Dawod, J Liu, S Gebremeskel, C Yan, A Sappong, B Johnston, ... Scientific Reports 10 (1), 13343, 2020 | 33 | 2020 |
| Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade C Yan, N Saleh, J Yang, CA Nebhan, AE Vilgelm, EP Reddy, JT Roland, ... Molecular Cancer 20, 1-21, 2021 | 32 | 2021 |
| Metastatic Melanoma Patient-derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK Inhibition RL Shattuck-Brandt, SC Chen, E Murray, CA Johnson, H Crandall, ... Clinical Cancer Research 26 (14), 3803-3818, 2020 | 30 | 2020 |
| Th9 and Th17 cells: the controversial twins in cancer immunity C Yan, A Richmond The Journal of Clinical Investigation 130 (7), 3409-3411, 2020 | 19 | 2020 |
| Nucleotide divergence and genetic relationships of Pseudoroegneria species C Yan, G Sun Biochemical Systematics and Ecology 39 (4-6), 309-319, 2011 | 18 | 2011 |
| IL‐17R deletion predicts high‐grade colorectal cancer and poor clinical outcomes C Yan, WY Huang, J Boudreau, A Mayavannan, Z Cheng, J Wang International Journal of Cancer 145 (2), 548-558, 2019 | 15 | 2019 |
| Phylogenetic analysis revealed reticulate evolution of allotetraploid Elymus ciliaris C Yan, Q Hu, G Sun Molecular Phylogenetics and Evolution 69 (3), 805-813, 2013 | 15 | 2013 |
| Nuclear and chloroplast DNA phylogeny reveals complex evolutionary history of Elymus pendulinus C Yan, Q Hu, G Sun Genome 57 (2), 97-109, 2014 | 14 | 2014 |
| Harnessing the Potential of CD40 Agonism in Cancer Therapy Y Zhou, A Richmond, C Yan Cytokine & Growth Factor Reviews (75), 40-56, 2024 | 10 | 2024 |
| IL-17RC is critically required to maintain baseline A20 production to repress JNK isoform-dependent tumor-specific proliferation. C Yan, Y Lei, TJ Lin, DW Hoskin, A Ma, J Wang Oncotarget 8 (26), 43153, 2017 | 10 | 2017 |
| Generation of Orthotopic Patient-Derived Xenografts in Humanized Mice for Evaluation of Emerging Targeted Therapies and Immunotherapy Combinations for Melanoma C Yan, CA Nebhan, N Saleh, R Shattuck-Brandt, SC Chen, GD Ayers, ... Cancers 15 (14), 3695, 2023 | 8 | 2023 |
| Proximity of immune and tumor cells underlies response to BRAF/MEK-targeted therapies in metastatic melanoma patients C Yan, SC Chen, GD Ayers, CA Nebhan, JT Roland, VL Weiss, ... NPJ Precision Oncology 6 (1), 6, 2022 | 8 | 2022 |
ann richmondVanderbilt University OR Emory OR Veterans AffairsDirección de correo verificada de vanderbilt.edu
